Latest Kaiser Health News Stories
Why Did Novartis Pay Trump’s Lawyer $1.2 Million? Look At Its Drug Prices
Promises to control pharma prices threaten profits for Switzerland-based Novartis, which sells some of the costliest drugs in the world.
Consumers Brace For Premium Hikes While Lawmakers Grasp At Remedies
Health insurers’ initial premium requests indicate stiff price hikes for consumers, just as bipartisan talks in Congress fall flat.
Podcast: KHN’s ‘What The Health?’ The Politics Of Rising Premiums And Menu Labeling
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Stephanie Armour of The Wall Street Journal, Margot Sanger-Katz of The New York Times and Anna Edney of Bloomberg News discuss the latest on the politics of rising premiums, GOP efforts to take back money from the Children’s Health Insurance Program, and the controversy over new rules requiring calorie information on menus. Plus for extra credit, the panelists recommend their favorite health stories of the week.
Midterm Elections Are Shaping Up To Be A Referendum On Trumpism
Even voters who say they are more enthusiastic about voting in this congressional election than in past ones are not motivated by any specific issue. But, according to a poll out Thursday, health care policies rank high among topics voters want candidates to address.
Hoping To See Your Doctor Via Telemedicine? Here’s A Quick Guide.
All private health plans, Medicare, state Medicaid programs and the VA now cover some e-visits — albeit with restrictions.
4 Takeaways From Trump’s Plan To Rescind CHIP Funding
President Donald Trump is recommending that Congress approve his plan to take back about $7 billion in funding for the Children’s Health Insurance Plan. Experts are divided about whether it would have any effect.
Medicare Beneficiaries Feel The Pinch When They Can’t Use Drug Coupons
Federal law prohibits them from using the coupons drugmakers offer to help patients cover their share of a medicine’s cost.
‘Pharma Bro’ Shkreli Is In Prison, But Daraprim’s Price Is Still High
The saga of Martin Shkreli and Turing Pharmaceuticals focused a lot of attention on prescription drug prices, but no reversal of the exponential price increases for the lifesaving drug Daraprim resulted. The story offers an object lesson into the interworkings of the pharmaceutical market.
Weak Oversight Blamed For Poor Care At California Nursing Homes Going Unchecked
The scathing report cites a significant increase in cases of poor care — especially ones with the potential to cause serious injuries or death. A state lawmaker called the findings “very, very disturbing.”
Podcast: KHN’s ‘What The Health?’ Medicaid, Privacy And Tom Price’s Return
Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Margot Sanger-Katz of The New York Times and Alice Ollstein of Talking Points Memo discuss the latest on states’ efforts to reshape their Medicaid programs, the kerfuffle over President Donald Trump’s medical records and comments by former Health and Human Services Secretary Tom Price about Congress’ repeal of the Affordable Care Act’s “individual mandate” penalty. Rovner also interviews Harvard professor Robert Blendon about the complex politics of health in the coming midterm elections.
Sprained Your Ankle? The Cost Of A Brace Could Sprain Your Wallet.
Your health insurance might not cover items such as wheelchairs, walkers, crutches and braces, or you may have to deal with a supplier that has a contract with your insurer.
As Proton Centers Struggle, A Sign Of A Health Care Bubble?
Companies pushed proton machines and counted on advertising, doctors and insurers to ensure a steady business treating cancer. But the dollars haven’t flowed in as expected.
‘A Persistent Puzzle’: Californians Embrace Medicaid — But Food Stamps? Not So Much.
The Golden State ranks near the bottom in its enrollment of eligible people in the food assistance program known as SNAP. Now state officials want to tap its robust Medicaid rolls to boost SNAP signups.
Best Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes, who reads everything on health care to compile our daily Morning Briefing, offers the best and most provocative stories for the weekend.
Dissecting The Rhetoric Vs. Reality Of Trump’s Tough Talk On Drug Prices
President Donald Trump’s upcoming speech on drug prices comes after months of public comments and debate about tackling the issue.
Readers Weigh In On Vitamin Use And The Big Pharma-Patient Advocacy Connection
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
Hospitals Lure Diabetes Patients With Self-Care Courses, But Costs Can Weigh Heavily
Self-management classes can help the tens of millions of Americans now diagnosed with Type 2 diabetes. But the education can come with a high price tag.
Peak Health Plan Premiums Give Rise To Activism — And Unconventional Solutions
For people who buy their health coverage rather than get it from the government or through work, Charlottesville, Va., has claimed the title of having the country’s highest health insurance costs, and its residents are fighting back.
4 New Ways You Can Avoid Fines For Not Having Health Insurance
Among changes by the Trump administration, new rules protect consumers living in areas with only one marketplace plan as well as those who oppose abortion and can’t find a plan that doesn’t cover the procedure.
Must-Reads Of The Week From Brianna Labuskes
KHN’s newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you don’t have to.
